Literature DB >> 9231837

Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training.

C A Roelen1, W R de Vries, H P Koppeschaar, C Vervoorn, J H Thijssen, M A Blankenstein.   

Abstract

The high affinity growth hormone-binding protein (GHBP) circulates in human blood and represents the extracellular domain of the growth hormone (GH) receptor. It is well known that repetitive bouts of endurance type exercise result in increased integrated GH secretion. As the effects of chronic exercise on plasma GHBP levels have never been studied systematically, we investigated the effect of 2 weeks of intense endurance training on plasma GHBP as well as on plasma insulin-like growth factor (IGF)-I levels in 10 healthy, young, non-obese men. IGF-I was measured as an indicator of the effects of GH release. We also studied 10 control subjects matched for sex, age and activity, who were instructed not to change their customary activities. GHBP was determined by FPLC size exclusion chromatography and subsequent Scatchard plot analysis of the binding data; IGF-I levels were measured by RIA. The results showed that plasma IGF-I and GHBP levels were increased in the subjects who followed the training program. IGF-I and GHBP changed from 252 +/- 56 ng/ml and 912 +/- 59 pmol/l before training, to 344 +/- 61 ng/ml (p < 0.01) and 1020 +/- 48 pmol/l (p < 0.01), respectively. Another effect of the training was that the aerobic capacity of these subjects was better utilized and endurance was improved. In contrast, plasma IGF-I, GHBP, utilization of aerobic capacity and endurance did not change significantly in the control subjects. We conclude that two weeks of strenuous endurance training lead to increased plasma IGF-I and high affinity GHBP levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231837     DOI: 10.1055/s-2007-972626

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  8 in total

1.  Effect of 6 weeks of sprint training on growth hormone responses to sprinting.

Authors:  Keith A Stokes; Mary E Nevill; Paul W Cherry; Henryk K A Lakomy; George M Hall
Journal:  Eur J Appl Physiol       Date:  2004-02-17       Impact factor: 3.078

2.  Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes.

Authors:  Melvin E Klegerman; Shaoling Huang; Devang Parikh; Janet Martinez; Sasha M Demos; Hayat A Onyuksel; David D McPherson
Journal:  Biochim Biophys Acta       Date:  2007-04-14

3.  Association between dynamic exercise therapy and IGF-1 and IGFBP-3 concentrations in the patients with rheumatoid arthritis.

Authors:  Meltem Alkan Melikoglu; Saliha Karatay; Kazim Senel; Fatih Akcay
Journal:  Rheumatol Int       Date:  2005-06-03       Impact factor: 2.631

4.  Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3.

Authors:  J L Chicharro; A López-Calderon; J Hoyos; A I Martín-Velasco; G Villa; M A Villanúa; A Lucía
Journal:  Br J Sports Med       Date:  2001-10       Impact factor: 13.800

Review 5.  Endogenous anabolic hormone responses to endurance versus resistance exercise and training in women.

Authors:  Leslie A Consitt; Jennifer L Copeland; Mark S Tremblay
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 6.  Growth factors as mediators of exercise actions on the brain.

Authors:  M Llorens-Martín; I Torres-Alemán; José L Trejo
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

Review 7.  Brain repair and neuroprotection by serum insulin-like growth factor I.

Authors:  Eva Carro; Jose Luis Trejo; Angel Núñez; Ignacio Torres-Aleman
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

8.  Igf-I and fgf-2 responses to wingate anaerobic test in older men.

Authors:  Ruthie Amir; David Ben-Sira; Moran Sagiv
Journal:  J Sports Sci Med       Date:  2007-06-01       Impact factor: 2.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.